Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22049967 | 0.82 | CYP2D6 (0.44) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL22049969 | 0.82 | CYP2D6 (0.44) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL23992541 | 0.78 | — | — | |
| SCHEMBL22364744 | 0.78 | — | — | |
| SCHEMBL8319997 | 0.77 | CYP2D6 (0.42) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL25695916 | 0.72 | CYP2D6 (0.40) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL13300930 | 0.72 | CYP2D6 (0.47) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL2603296 | 0.71 | CYP2D6 (0.45) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL16980430 | 0.70 | CYP2D6 (0.37) | CYP2D6KDM4EMEN1ALDH1A1LMNA | |
| SCHEMBL22758560 | 0.70 | CYP2D6 (0.37) | CYP2D6KDM4EMEN1ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019075265-A1 | PYRIDINE, PYRAZINE, AND TRIAZINE COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS | Revolution Medicines, Inc. (US) | 2019-04-18 | — | — | WO | disclosed |